Study Details

General Information

Axcella DM2/NAFLD AXA1125

A 12-Week, Multicenter, Open-label Cohort Study of the Safety and Tolerability of AXA1125 in Patients with Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease (NAFLD), Protocol # AXA1125-002

ProtocolAXA1125-002
Identifier
UID8ea8c9a8-0a12-47aa-ae25-d44b98bde101
StatusDone - Archived
Phase
CategoryDiabetes Type 2/NAFLD / Adult
Launch Year2017
NCT Number-
Created2017-08-22 15:22
Last Updated2017-08-22 15:22

Description

No description provided.

Comment

PCRS

Target Dates

NameDateRequired
Enrollment Closed2018-04-03No
Enrollment Open2017-11-07No
First Patient First VisitNo
Site Initiation Mtg.2017-10-04No
PI Meeting StartNo
PI Meeting EndNo
PI Meeting ArrivalNo
PI Meeting DepartureNo
Closeout Date2018-09-18No
Final PatientVisitNo
PreStudy Selection VisitNo
Target Date 12No
Target Date 13No
Target Date 14No

Leadership

RoleStaffLoginRequired
PrincipalMohseni, RizwanaRMohseniNo
RecruiterMiss, SalomonSMissNo
CoordinatorValenzuela, LouisitoLValenzuelaNo
RegulatoryRamirez, ClaudiaCRamirezNo

Custom Fields

No custom fields.

Sponsor & Organization

SponsorAxcella Health, Inc.
DivisionAxcella Health, Inc.
TeamAxcella Health, Inc.
Managing SiteCatalina Research Institute, LLC
Organization

Contacts

IRB Ref
CROIntegrium Clinical Research
CRO Ref
Correspondence0

Opportunity

Probability0
Comment
Status ColorGainsboro
Currency-
Mayra Sibley

2 Hours

Hi there, I'm Jesse and you?
You

3 minutes

My name is Anne Clarc.
Mayra Sibley

40 seconds

Nice to meet you Anne.
How can i help you?